Synthesis and anti-HIV-1 activity of a series of 1-alkoxy-5-alkyl-6- (arylthio)uracils

Journal of Medicinal Chemistry

Volumn 40, Issue 15, 1997, Pages 2363-2373

  Kim, Dae Kee ^a   Gam, Jongsik ^a   Kim, Young Woo ^a   Lim, Jinsoo ^a   Kim, Hun Taek ^a   Kim, Key H ^a  

^a Sunkyong Industries   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 [(3,5 DIMETHYLPHENYL)THIO] 1 (3 HYDROXYPROPOXY) 5 ISOPROPYLURACIL; 6 [(3,5 DIMETHYLPHENYL)THIO] 5 ISOPROPYL 1 PROPOXYURACIL; ANTIRETROVIRUS AGENT; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-HIV AGENTS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; URACIL;

EID: 0030759473     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9607921     Document Type: Article

References (39)

1. De Clercq, E. Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV Infections. J. Med. Chem. 1995, 38, 2491-2517.
2. Connolly, K. J.; Hammer, S. M. Antiretrovial Therapy: Reverse Transcriptase Inhibition. Antimicrob. Agents Chemother. 1992, 36, 245-254.
3. Mitsuya, H.; Weinhold, K. J.; Furman, P. A.; St. Clair, M. H.; Nusinoff-Lehrman, S.; Gallo, R. C.; Bolognesi, D. P.; Barry, D. W.; Broder, S. 3′-Azido-3′-deoxythymidine (BW A509U): An Antiviral Agent That Inhibits the Infectivity and Cytopathic Effect of Human T-lymphotropic Virus Type III/lymphadenopathy-associated Virus In Vitro. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 7096-7100.
4. Fischl, M. A.; Richman, D. D.; Grieco, M. H.; Gottlieb, M. S.; Volberding, P. A.; Laskin, O. L.; Leedom, J. M.; Groopman, J. E.; Mildvan, D.; Schooley, R. T.; Jackson, G. G.; Durack, D. T.; King, D.; The AZT Collaborative Working Group. The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-related Complex: A Double-blind, Placebo-controlled Trial. N. Engl. J. Med. 1987, 317, 185-191.
5. Richman, D. D.; Fischl, M. A.; Grieco, M. H.; Gottlieb, M. S.; Volberding, P. A.; Laskin, O. L.; Leedom, J. M.; Groopman, J. E.; Mildvan, D.; Hirsch, M. S.; Jackson, G. G.; Durack, D. T.; Nusinoff-Lehrman, S.; The AZT Collaborative Working Group. The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-related Complex: A Double-blind, Placebo-controlled Trial. N. Engl. J. Med. 1987, 317, 192-197.
6. Mitsuya, H.; Broder, S. Inhibition of the in vitro Infectivity and Cytopathic Effect of Human T-lymphotropic Virus Type III/lymphadenopathy-associated Virus (HTLV-III/LAV) by 2′,3′-Dideoxynucleosides. Proc. Natl. Acad. Sci. U.SA. 1986, 83, 1911-1915.
7. Bozzette, S. A.; Richman, D. D. Salvage Therapy for Zidovudine-intolerant HIV-infected Patients with Alternating and Intermittent Regimens of Zidovudine and Dideoxycytidine. Am. J. Med. 1990, 88 (Suppl. 5B), 24S-26S.
8. Dunkle, L.; Cross, A.; Gugliotti, R.; Martin, R.; Browne, M.; Murray, H. Dose Escalating Study of Safety and Efficacy of Dideoxydidehydrothymidine (d4T) for HIV Infection. Antiviral Res. 1990, Suppl. I, Abst 145.
9. Merluzzi, V. J.; Hargrave, K. D.; Labadia, M.; Grozinger, K.; Skoog, M.; Wu, J. C.; Shin, C.-K.; Eckner, K.; Hattox, S.; Adams, J.; Rosenthal, A. S.; Faanes, R.; Eckner, R. J.; Koup, R. A.; Sullivan, J. L. Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor. Science 1990, 250, 1411-1413.
10. Pauwels, R.; Andries, K.; Desmyter, J.; Schols, D.; Kukla, M. J.; Breslin, H. J.; Raeymaeckers, A.; Van Gelder, J.; Woestenborghs, R.; Heykants, J.; Schellekens, K.; Janssen, M. A. C.; De Clercq, E.; Janssen, P. A. J. Potent and Selective Inhibition of HIV-1 Replication in vitro by a Novel Series of TIBO Derivatives. Nature 1990, 343, 470-474.
11. Romero, D. L.; Busso, M.; Tan, C. K.; Reusser, F.; Palmer, J. R.; Poppe, S. M.; Aristoff, P. A.; Downey, K. M.; So, A. G.; Resnick, L.; Tarpley, W. G. Nonnucleoside Reverse Transcriptase Inhibitors That Potently and Specifically Block Human Immunodeficiency Virus Replication. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8806-8810.
12. Saari, W. S.; Hoffman, J. M.; Wai, J. S.; Fisher, T. E.; Rooney, C. S.; Smith, A. M.; Thomas, C. M.; Goldman, M. E.; O'Brien, J. A.; Nunberg, J. H.; Quintero, J. C.; Schleif, W. A.; Emini, E. A.; Stern, A. M.; Anderson, P. S. 2-Pyridinone Derivatives: A New Class of Nonnucleoside HIV-1-Specific Reverse Transcriptase Inhibitors. J. Med. Chem. 1991, 34, 2922-2925.
13. Miyasaka, T.; Tanaka, H.; Baba, M.; Hayakawa, H.; Walker, R. T.; Balzarini, J.; De Clercq, E. A Novel Lead for Specific Anti-HIV-1 Agents: 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)-thymine. J. Med. Chem. 1989, 32, 2507-2509.
14. Camarasa, M. J.; Pérez-Pérez, M. J.; San-Félix, A.; Balzarini, J.; De Clercq, E. 3′-Spironucleosides (TSAO derivatives), a New Class of Specific Human Immunodeficiency Virus Type 1 Inhibitors: Synthesis and Antiviral Activity of 3′-Spiro-5′-[4″-amino-1″,2″-oxathiole-2″, 2″-dioxide]pyrimidine Nucleosides. J. Med. Chem. 1992, 35, 2721-2727.
15. De Clercq, E. HIV-1-Specific RT Inhibitors: Highly Selective Inhibitors of Human Immunodeficiency Virus Type 1 That Are Specifically Targeted at the Viral Reverse Transcriptase. Med. Res. Rev. 1993, 13, 229-258.
16. Baba, M.; De Clercq, E.; Tanaka, H.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Umezu, K.; Nakashima, H.; Mori, S.; Shigeta, S.; Walker, R. T.; Miyasaka, T. Potent and Selective Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) by 5-Ethyl-6-phenylthiouracil Derivatives Through Their Interaction with the HIV-1 Reverse Transcriptase. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2356-2360.
17. Baba, M.; De Clercq, E.; Iida, S.; Tanaka, H.; Nitta, I.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Umezu, K.; Nakashima, H.; Shigeta, S.; Walker, R. T.; Miyasaka, T. Anti-Human Immunodeficiency Virus Type 1 Activities and Pharmacokinetics of Novel 6-Substituted Acyclouridine Derivatives. Antimicrob. Agents Chemother. 1990, 34, 2358-2363.
18. Tanaka, H.; Baba, M.; Hayakawa, H.; Sakamaki, T.; Miyasaka, T.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R. T.; Balzarini, J.; De Clercq, E. A New Class of HIV-1-Specific 6-Substituted Acyclouridine Derivatives: Synthesis and Anti-HIV-1 Activity of 5- or 6-Substituted Analogues of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J. Med. Chem. 1991, 34, 349-357.
19. Tanaka, H.; Baba, M.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Synthesis and Anti-HIV-1 Activity of 2-, 3-, and 4-Substituted Analogues of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J. Med. Chem. 1991, 34, 1394-1399.
20. Tanaka, H.; Baba, M.; Saito, S.; Miyasaka, T.; Takashima, H.; Sekiya, K.; Ubasawa, M.; Nitta, I.; Walker, R. T.; Nakashima, H.; De Clercq, E. Specific Anti-HIV-1 "Acyclonucleosides" Which Cannot Be Phosphorylated: Synthesis of Some Deoxy Analogues of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine. J. Med. Chem. 1991, 34, 1508-1511.
21. Goudgaon, N. M.; Schinazi, R. F. Activity of Acyclic 6-(Phenylselenenyl)pyrimidine Nucleosides against Human Immunodeficiency Viruses in Primary Lymphocytes. J. Med. Chem. 1991, 34, 3305-3309.
22. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Structure-Activity Relationships of 1-[(2-Hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT) Analogues: Effect of Substitutions at the C-6 Phenyl Ring and at the C-5 position on Anti-HIV-1 Activity. J. Med. Chem. 1992, 35, 337-345.
23. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Synthesis and Antiviral Activity of Deoxy Analogs of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as Potent and Selective Anti-HIV-1 Agents. J. Med. Chem. 1992, 35, 4713-4719.
24. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Inouye, N.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Synthesis and Antiviral Activity of 6-Benzyl Analogs of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as Potent and Selective Anti-HIV-1 Agents. J. Med. Chem. 1995, 38, 2860-2865.
25. Kim, D.-K.; Kim, H.-T.; Lim, J.; Gam, J.; Kim, Y.-W.; Kim, K. H.; Shin, Y. O. Synthesis and Anti-HIV-1 Activity of 1,5-Dialkyl-6-(arylselenenyl)uracils and -2-Thiouracils. J. Heterocycl. Chem. 1996, 33, 885-894.
26. Harnden, M. R.; Parkin, A.; Wyatt, P. G. Synthesis of 9-(3-Hydroxypropoxy)guanine, a Novel Antiviral Acyclonucleoside. Tetrahedron Lett. 1988, 29, 701-704.
27. Harnden, M. R.; Wyatt, P. G.; Boyd, M. R.; Sutton, D. Synthesis and Antiviral Activity of 9-Alkoxypurines 1. 9-(3-Hydroxypropoxy)- and 9-[3-Hydroxy-2-(hydroxymethyl)propoxy]purines. J. Med. Chem. 1990, 33, 187-196.
28. Bailey, S.; Harnden, M. R.; Jarvest, R. L.; Parkin, A.; Boyd, M. R. Synthesis and Antiviral Activity of 9-Alkoxypurines. 2. 9-(2,3-Dihydroxypropoxy)- and 9-(3,4-Dihydroxybutoxy)-, and 9-(1,4-Dihydroxybut-2-oxy)purines. J. Med. Chem. 1991, 34, 57-65.
29. Parkin, A. Analogues of Acyclonucleoside Diphosphates. The Synthesis of a Series of Diphosphonate Derivatives of Pyrimidines and Purines. J. Chem. Soc., Perkin Trans. 1 1991, 2983-2990.
30. Harnden, M. R.; Jennings, L. J.; Parkin, A. Synthesis of 1-(Phosphonomethoxyalkoxy)pyrimidines, a Novel Series of Acyclonucleotide Analogues. Synthesis 1991, 947-950.
31. Kim, D.-K.; Kim, Y.-W.; Gam, J.; Lim, J.; Kim, K. H. A Convenient Approach to the Synthesis of 6-Substituted 1,5-Dialkyluracils and -2-Thiouracils. Tetrahedron Lett. 1995, 36, 6257-6260.
32. Ali, S. M.; Tanimoto, S. A General, High Yield Synthesis of α-Oxoketene Dithioacetals and O-(1-Alkoxy-2,2-dialkyl)vinyl S-Alkyl Dithiocarbonates from Carboxylic Esters. J. Chem. Soc., Chem. Commun. 1989, 684-685.
33. Ali, S. M.; Tanimoto, S. General, High Yield Synthesis of α-Oxoketene Dithioacetals and O-(1-Alkoxy-2,2-dialkyl)vinyl N,N-Diisopropylammonium Dithiocarbonates. Bull. Inst. Chem. Res., Kyoto Univ. 1990, 68, 199-207.
34. Tanaka, H.; Iijima, S.; Matsuda, A.; Hayakawa, H.; Miyasaka, T.; Ueda, T. The Reaction of 6-Phenylthiouridine with Sulfur Nucleophiles: A Simple and Regiospecific Preparation of 6-Alkythiouridines and 6-Alkylthiouridylic Acids. Chem. Pharm. Bull. 1983, 31, 1222-1227.
35. Weislow, O. S.; Kiser, R.; Fine, D. L.; Bader, J.; Shoemaker, R. H.; Boyd, M. R. New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst. 1989, 81, 577-586.
36. Mavunkel, B. J.; Rzeszotarski, W. J.; Kaplita, P. V.; DeHaven-Hudkins, D. L. Synthesis and Opioid Activities of Some Naltrexone Oxime Ethers. Eur. J. Med. Chem. 1994, 29, 659-666.
37. Theilacker, W.; Ebke, K. Darstellung von O-Alkyl-hydroxy-laminen. Angew. Chem. 1956, 68, 303.
38. Koroniak, H.; Jankowski, A.; Kransnowski, M. Facile Large Scale Synthesis of 5-Alkyluracils. Org. Prep. Proced. Int. 1993, 25, 563-568.
39. Nunberg, J. H.; Schleif, W. A.; Boots, E. J.; O'Brien, J. A.; Quintero, J. C.; Hoffman, J. M.; Emini, E. A.; Goldman, M. E. Viral Resistance to Human Immunodeficiency Virus Type 1-Specific Pyridinone Reverse Transcriptase Inhibitors. J. Virol. 1991, 65, 4887-4892.